News › Industry News, News

Ozempic, Mounjaro Lawsuits Consolidated in Federal Multidistrict Litigation

February 6, 2024
Medical law: books, gavel and stethoscope

A federal panel has consolidated at least 55 lawsuits against pharmaceutical companies Novo Nordisk and Eli Lilly into a multidistrict litigation in the Eastern District of Pennsylvania.

The lawsuits claim that these companies did not adequately warn people about the severe side effects associated with a class of prescription drugs including Ozempic and Mounjaro.

Plaintiffs’ lawyers anticipate filing up to 10,000 lawsuits related to Ozempic and similar drugs as part of the MDL.

Read more at Drugwatch.com >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • BTL Establishes New Laser Division and Introduces Exolase One
    • SkinMedica Launches Barrier Calming Cream
    • CEDR HR Solutions Supports AmSpa Members as Platinum Vendor Affiliate
    • Galderma Opens New U.S. and Latin America Headquarters in Miami
    • Raging Agency Becomes Silver Vendor Affiliate with the American Med Spa Association
Advertisement